Upgrade to SI Premium - Free Trial

Deciphera Pharmaceuticals (DCPH) Tops Q2 EPS by 6c

August 4, 2022 7:18 AM

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q2 EPS of ($0.60), $0.06 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $32.5 million versus the consensus estimate of $30.58 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

Categories

Earnings

Next Articles